Hirosue et al., J. Controlled Release, 70, 231-242, 2001.* |
Anderson Human gene therapy pp. 25-30 vol. 1998.* |
Verma et al. Gene therapy promises, problems and prospects pp. 239-242, 1997.* |
Chickering, D. et al., “Bioavailability of Bioadhesive Polyanhydride Delivery Systems”, Proc. Int. Symp. Control, Release Bioact. Mater., 1995, 22:169-170, #320. |
Chickering, D.E. et al., “Bioadhesive microspheres: I. A novel electrobalance-based method to supply adhesive interactions between individual microspheres and intestinal mucosa”, Journal of Controlled Release, 1995, 34:251-261. |
Crystal, R.G., “Transfer of Genes to Humans: Early Lessons and Obstacles to Sucess”, Science, 1995, vol. 270, pp. 404-410. |
Duchene, D. et al., “Pharmaceutical and Medical Aspects of Bioadhesive Systems for Drug Administration”, Drug Development and Industrial Pharmacy, 1988, 14:2&3:283-318. |
Duchene, D. et al., “Principle and investigation of the bioadhesion mechanism of solid dosage forms”, Biomaterials, 1992, 13:10:709-714. |
Eldridge, J. H. et al., “Biodegradable Microspheres as a Vaccine Delivery System”, Molecular Immunology, 1991, 28:3:287-294. |
Eldridge, J. H. et al., “X Pulsatile Delivery of Vaccines”, Paperback APV, 1993, 33:163-176. |
Eldridge, J.H. et al., “Biodegradable poly(DL-lactide-co-glycolide) microspheres”, Characteristics and Use of New-Generation Adjuvants, 44th Forum in Immunology, pp. 557-563, 1992. |
Fynan, E.F. et al., “DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations”, Proc. Natl. Acad. Sci. USA, Dec. 1993, 90:11478-11482. |
Gunzburg, W.H. et al., “Virus vector design in gene therapy”, Reviews Molecular Medicine Today, 1995, pp. 410-417. |
Hodgson, C.P., “Biologicals & Immunologicals Advances in vector systems for gene therapy”, Exp. Opin. on Ther. Patents, 1995, 5(5):459-468. |
Kaelble, D.H. et al., “A surface energy analysis of bioadhesion”, Polymer., 1977, 18:475-482. |
Ledley, F.D., “Nonviral Gene Therapy: The Promise of Genes as Pharmaceutical Products”, Review Human Gene Therapy, Sep. 1995, 6:1129-1144. |
Marshall, E., “Gene Therapy's Growing Pains”, Science, Aug. 25, 1995, 269(5227):1050-1055. |
Morris, W. et al., “Potential of polymer microencapsulation technology for vaccine innovation”, Vaccine, 1994, vol. 12, No. 5, pp. 5-11. |
Orkin, S.H. et al., “Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy”, NIH, Dec. 7, 1995, pp. 1-40. |
Park, H. et al., “Physico-chemical properties of water insoluble polymers important to mucin/epithelial Adhesion”, J. of Controlled Release, 1985, 2:47-57. |
Pilewski, J.M. et al., “Adenovirus-mediated Gene Transfer to Human Bronchial Submucosal Glands Using Xenografts”, American Physiological Society, 1995, pp. L657-L665. |
Sawhney, A.S. et al., “Bioerodible Hydrogels Based on Photopolymerized Poly(ethylene glycol)-co-poly(α-hydroxy acid) Diacrylate Macromers”, Macromolecules, 1993, 26:581-587. |
Spychal, R.T. et al., “Measurement of the Surface Hydrophobicity of Human Gastrointestinal Mucosa”, Gastroenterology, 1989, 97:104-11. |
Staats, H.F. et al., “Mucosal immunity to infection with implications for vaccine development”, Current Opinion in Immunology, 1994, 6:572-583. |